Results 11 to 20 of about 25,112 (170)

Functional analysis of human T lymphotropic virus type 2 Tax proteins [PDF]

Retrovirology, 2006
Background The Tax proteins encoded by human T lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) are transcriptional activators of both the viral long terminal repeat (LTR) and cellular promoters via the CREB and NFkB pathways. In contrast to HTLV-1,
Gautier Virginie, Lewis Martha, Watters Karen, Lillis Lorraine, Sheehy Noreen, Hall William   +5 more
doaj   +3 more sources

Human T-Lymphotropic Virus-1/2 Infection in Central Brazil Prisons: A Multicenter Study [PDF]

Frontiers in Microbiology, 2022
Human T-lymphotropic virus (HTLV) infection is endemic in some group populations. Prisoners are at high risk of acquiring HTLV infection mainly due to the environment of closed penal institutions, socioeconomic conditions, and risk behaviors.
Larissa Melo Bandeira, Marco Antonio Moreira Puga, Julio Croda, Julio Croda, Maurício Antonio Pompílio, Carolina Amianti, Grazielli Rocha de Rezende, Ana Rita Coimbra Motta-Castro, Ana Rita Coimbra Motta-Castro   +8 more
doaj   +3 more sources

Work-Related Human T-lymphotropic Virus 1 and 2 (HTLV-1/2) Infection: A Systematic Review [PDF]

Viruses, 2021
Human T-lymphotropic virus 1 and 2 (HTLV-1/2) belong to the delta group of retroviruses which may cause a life-long infection in humans, HTLV-1 leading to adult T-cell leukemia/lymphoma and other diseases. Different transmission modes have been described,
Angela Stufano, Hamid Reza Jahantigh, Francesco Cagnazzo, Francesca Centrone, Daniela Loconsole, Maria Chironna, Piero Lovreglio   +6 more
doaj   +4 more sources

Prevalence of human T-lymphotropic virus 1/2 in Nigeria’s capital territory and meta-analysis of Nigerian studies

SAGE Open Medicine, 2019
Objectives: This study was aimed at determining human T-lymphotropic virus 1/2 prevalence among apparently healthy, immunocompromised and haematologic malignant individuals in Nigeria’s capital, as well as meta-analysis of all Nigerian studies until date.
Nneoma Confidence JeanStephanie Anyanwu, Elijah Ekah Ella, Maryam Aminu, Maleeha Azam, Muhammad Ajmal, Haruna Makonjuola Kazeem   +5 more
doaj   +3 more sources

Human T-lymphotropic virus 2 (HTLV-2) prevalence of blood donors in the state of Pará, Brazil. [PDF]

Braz J Microbiol, 2023
The present study had the objective to describe the molecular prevalence and epidemiological aspects of the human T-lymphotropic virus 2 (HTLV-2) infection in the blood donor population of the Pará state.The present study is a descriptive, retrospective, and cross-sectional review of epidemiological, serological, and molecular data on inapt blood ...
Correa LP, da Costa Farias F, Dos Santos Barile KA, Palmeira MK, de Melo Amaral CE.   +4 more
europepmc   +3 more sources

Human T lymphotropic virus types 1 and 2: a point of view [PDF]

Revista Brasileira de Hematologia e Hemoterapia, 2013
Reported at the beginning of the 1980s, Human T lymphotropic viruses type 1 and 2 (HTLV1, HTLV 2) were the first retroviruses to have been detected in human beings. HTLV 1 was isolated from adult T-cell leukemia (ATL) and first described by Takatsuki et al. in Japan in 1976, as a malignancy that only affects T cells and only in adults(1, 2).
Angela Cristina Malheiros Luzo
doaj   +3 more sources

Clinical Outcome in Human T-Lymphotropic Virus Type 2 Carriers Following Organ Transplantation [PDF]

Transplantation Proceedings, 2021
Frequent and rapid development of myelopathy has been reported in individuals with human T-lymphotropic virus type 1 (HTLV-1) infection following solid organ transplantation. There is no information regarding HTLV-2, a closely related virus that often infects injection drug users.This study includes a retrospective analysis of all consecutive organ ...
Rafael Benito, Joaquina Gil, Juan Sahagún, Vicente Soriano   +3 more
openaire   +4 more sources

Assessment of Awareness and Knowledge Regarding Human T-Lymphotropic Virus Type 1 (HTLV-1) Among Healthcare Workers at Imam Khomeini Hospital Complex, Tehran, in 2023-2024, A Cross-Sectional Descriptive-Analytical Study. [PDF]

Health Sci Rep
ABSTRACT Background and Aim Human T‐Lymphotropic Virus Type 1 (HTLV‐1), is responsible for serious diseases such as Adult T‐cell leukemia/lymphoma (ATLL) and HTLV‐1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). This research aimed to explore the level of awareness and knowledge of HTLV‐1 among healthcare professionals working at Imam ...
Letafati A, Goudarzi Y, Sheikhi M, Afzali M, Norouzi M, Rouzbahani KA, Ghasemi M, Sadeghi A, Mozhgani SH.   +8 more
europepmc   +2 more sources

High prevalence of human T-lymphotropic virus 2 (HTLV-2) infection in villages of the Xikrin tribe (Kayapo), Brazilian Amazon region. [PDF]

BMC Infect Dis, 2019
Studies have shown that the human T-lymphotropic virus 2 (HTLV-2) is endemic in several indigenous populations of the Brazilian Amazon and molecular analyses have shown the exclusive presence of HTLV-2 subtype 2c among the indigenous groups of this geographical region.The present study characterizes the prevalence of HTLV-2 infection in three new ...
Braço ILJ, de Sá KSG, Waqasi M, Queiroz MAF, da Silva ANR, Cayres-Vallinoto IMV, Lima SS, de Oliveira Guimarães Ishak M, Ishak R, Guerreiro JF, Vallinoto ACR.   +10 more
europepmc   +5 more sources

Malignant Otitis Externa in Central Australia: A 15-Year Retrospective Review Between 2009 and 2024. [PDF]

Med J Aust
ABSTRACT We performed a 15‐year retrospective audit of all cases of malignant otitis externa (MOE) referred to Alice Springs Hospital in Central Australia from 2009 to 2024, the largest Australian series of MOE. Data on demographics, risk factors, microbiological culture results, management and outcomes were collected, identifying 64 cases of MOE, with
Drewett GP, Jacob M, Culhane B, Booth A, Wright C, Thomas S, Abraham A.   +6 more
europepmc   +2 more sources